Q4 2024 Earnings Conference Call February 7, 2025 3:00 AM ETCompany ParticipantsNicolas Hieronimus - CEOChristophe Babule ...
After a final cold night in light winds on the Bay of Biscay, Italy’s Giancarlo Pedote completed his second consecutive ...
The skincare obsessed generation is seemingly undoing all their work for a temporary, killer glow. We unpack Australia's ...
Despite the large debt balance compared with its current level of cash, we expect healthy cash generation from Kenvue to meet all of its near-term financial obligations. Only $1.5 billion of debt is ...
Roche has secured a new FDA approval for its first companion diagnostic test aimed at identifying breast cancer patients with ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 43 tables and 86 figures, this 160-page report ?Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 39 tables and 61 figures, this 133-page report Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, ...
5d
News Medical on MSNNeurostimulation improves movement in adults with spinal muscle atrophyA new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.
The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase is Your Competitive Edge Tod ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).
Tory Burch has offered what she calls a “twist-ed” take American sportswear in her new fall/winter collection at New York ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results